Medtronic's Reclaim deep-brain stimulation device

FDA approves new OCD treatment device

Hackensack, New Jersey, February 20: Patients with severe obsessive-compulsive disorder (OCD) may be treated with a new pacemakerdefine-like device that has the ability to control compulsive behavioral outbreaks.

FDA approves new OCD treatment device

The new device called Medtronic's Reclaim deep-brain stimulation (DBS) device has been approved by the FDA, under “humanitarian device exemption".

Though FDA has approved the device, it maintained that DBS can only be used for the most severely affected patients with OCD.

Syndicate content